ABSTRACT A method is presented that uses selective proton Nuclear Magnetic Resonance 
INTRODUCTION
The nicotinic acetylcholine receptor (AChR) is perhaps the best characterized receptor of a neurotransmitter, (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) but there remain many unanswered questions about the molecular level interactions between the receptor and its agonists. In particular, it is important to be able to distinguish between specific and nonspecific agonist binding; to be able to assess the importance of interaction between the ligand and the lipid; to have strategies to determine the conformation of the bound agonist; and finally, to have a simple, rapid, and reliable technique to measure agonist binding constants. These questions are well-suited for Nuclear Magnetic Resonance (NMR) spectroscopic investigation, and this manuscript describes results along these lines.
The method presented here is to monitor ligand binding to large receptor molecules by measuring selective spinlattice relaxation times (TI) of protons on the ligand. The physical picture is one where many small molecules bind and unbind to the receptor and bring back into solution information about their bound state. This information is then read out by selective T1 measurements on the small molecules. In this paper we show (a) that selective T, measurements are a very sensitive measure of ligand binding to the acetylcholine receptor, (b) that specific and Dr. Navon's present address is School of Chemistry, Tel-Aviv University, Tel-Aviv, Israel. nonspecific binding effects can be distinguished, and (c) that chemical amplification can be obtained by monitoring the on-off binding of many ligand molecules to a low concentration of receptor molecules.
MATERIALS AND METHODS

Treatment of the Data
We have a situation where a ligand, L, is binding to a receptor molecule, R, and the total ligand concentration is in large excess compared with the receptor concentration. This means that the total amount of ligand which is in the bound state is small. In this case, the spin-lattice relaxation of the protons on the ligand is described by: (19, (7) and (c) it broadens the NMR spectra. The amount of free asolectin, and therefore these undesirable side effects, were minimized by eluting the receptors from the affinity column with carbamylcholine without asolectin in the elution buffer.
Crude Acetylcholine Receptors. The electroplax organs were minced and added to an equal volume of pH 7.4 2X homogenization buffer (40 mM Na2PO4, 20 mM EGTA, 10 mM EDTA, 10 mM dithiothreitol, 20 mM benzamidine, 20 gg/ml leupeptin, 20 gg/ml antipain, and 20 U/ml trasylol (aprotinin)). Pepstatin (10 ,ug/ml), chymostatin (20 Ag/ml), and phenylmethylsulfonyl fluoride (0.1 mM)
were added during the first homogenization (Waring blender using eight low speed pulses of 15 s duration, each one separated by one min intervals). The homogenate was centrifuged for 10 min at 6,500 rpm (6,870 g) and poured through several layers of cheese cloth. The pellets were suspended in an equal volume of IX homogenization buffer (2X buffer diluted), recentrifuged, and the supernatant collected as before. The combined supernatants were centrifuged for 2 to 3 h at 13 K rpm (20,200 g). The supernatants were then discarded and the pellets were resuspended by adding 10 ml of the IX homogenization buffer to each tube. Protein concentrations (A280, where an absorbence of 1.0 corresponds to a value of 0.6 mg protein/ml [7] ) were determined on these crude membrane preparations, and the samples were stored frozen in liquid nitrogen until needed for further purification.
Purified Acetylcholine Receptors. The frozen membranes were thawed and brought to a final protein concentration of 2.5 mg/ml in the pH 7.4 purification buffer (20 mM tris-HCI, 100 mM NaCl, 50 mM KC1, 1 mM EDTA, 2 mM EGTA, 10 U/ml trasylol (aprotinin), 10 yg/ml leupeptin, 10 gg/ml antipain, 5 mM 2-mercaptoethanol). To this solution, stirring on ice, was added sodium cholate (previously recrystallized from 70% ethanol (8)) to a final cholate concentration of 1%. This solution was stirred on ice for 30 min and then centrifuged for 30 min at 35 K rpm using the Ti 45 rotor (96,000 g). The supernatant was combined with the affinity resin (see following section for preparation of the affinity resin) in a supernatant:resin volume ratio of 20:1 and stirred for 2-3 h at 40C.
After the resin had settled the excess solution was decanted off and the resin was poured into a column, and the column was eluted with 150 ml of the wash buffer (see below) at a fast rate. The protein was eluted from the resin with 50 ml of wash buffer which was 20 mM in carbamyl choline and collected in 1 ml fractions. Fractions were pooled according to their A2M, and for NMR samples, the pooled protein was vacuum concentrated down to 1-2 ml total volume. It was then dialyzed against three changes of dialysis buffer (20 mM tris-HCl, pH 7.4, 1 mM EGTA, 5 mM dithiothreitol, and 0.4% cholate). A fourth dialysis was performed against D20-containing dialysis buffer. For NMR samples, the pooled fractions after affinity chromatography were vacuum concentrated to 1-2 ml and dialyzed against three changes of dialysis buffer (20 nM phosphate, pH 7.4, 1 mM EDTA, 5 mM DTT, and 0.4% cholate), followed by three more dialyses against the same buffer prepared with D20.
The NMR samples were stable for several days at 230C, and for longer periods at 40C. Freezing the asolectin-containing sample destroyed the AChR's ability to bind nicotine. The stability (binding activity) of a preparation was monitored before and after long NMR runs by its selective T,.
Preparation of the Affinity Resin. Bromoacetylcholine bromide synthesis and the affinity resin preparation were carried out according to Damle et al. (29) , and cholate was purified according to Kagawa and Racker (30 
RESULTS AND DISCUSSION
Characterization of the Asolectin/Acetylcholine Preparation used for NMR Studies Freeze fracture replicas were used to characterize the general morphology of the receptor preparation. The photographs in Fig. 1 show that the samples contain primarily vesicles ranging from <0.02 to 0.2 ,um in diameter. Some large multilamellar vesicles are also present (see Fig. 1 b) . The protein (the pocked small structures, as confirmed by examining a vesicle preparation without protein) in these multilamellar vesicles (Fig. 1 b) is encased within several layers of lipid bilayer. The presence of such structures may partially explain the well-known difficulties of '251I-labeled a-bungarotoxin binding assays, (7, 31) since a small protein such as a-bungarotoxin (74 amino acids) may not diffuse well through the multilamellar structures to protein entrained on the inner layers. It appears that -1% of the vesicles are large multilamellar vesicles which may contain up to 20% of the total AChR in the sample.
Characterization of Acetylcholine Esterase Activity of the Receptor Preparation
It is well-known that these receptor preparations contain residual acetylcholine esterase activity because the affinity column purification step also selects for acetylcholine esterase. The esterase activity from this purification scheme was measured by NMR at a low receptor concentration (5 ,uM in binding sites) by monitoring the intensity of the acetylcholine tetramethylammonium resonance (2.19 ppm) and the intensity of the growing acetate peak (1.93 ppm) as a function of time at 230C. The sum of these peak intensities remained constant, as expected. The hydrolysis monitored by NMR is a zero order reaction (k = 0.084 ± 0.001 min-').
Adding diisopropyl fluorophosphate to the AChR/ asolectin preparation completely inhibited acetylcholine esterase activity as measured by NMR experiments. A small amount of white precipitate formed when the diisopropyl fluorophosphate (1 ,l) was added to one to 2 ml of the AChR/asolectin solution, but NMR relaxation measurements show that nicotine binding was unaffected.
General Characterization of the NMR Spectrum of Nicotine plus the Receptor/Asolectin Preparation The data in Table I illustrate the effect of asolectin, AChR, and competing ligands on the relaxation of the nicotine protons. In D20, the nicotine HB relaxation times are between 3 and 4 s. The nicotine HB relaxation time observed when asolectin vesicles are present at a concentration similar to that present in the titration experiments is considerably shorter than the relaxation time in D20. This suggests a large amount of nicotine binding to the lipid vesicles, which is not surprising since the positively charged nicotine can interact strongly with the charged lipid head groups. This binding is expected to be nonspecific, and the exchange rate is probably in the fast exchange limit (TI bound »> Tbound).
Large changes occur in the selective relaxation times of the nicotine HB proton in the presence of the AChR (Table   I, Table II (first row) .
Competitive Titrations for the Receptor Binding Site. Table I provides illustrative raw data for the competitive titrations; Fig. 5 shows the competitive data plotted for one acetylcholine and for one carbamylcholine titration. Table II summarizes the slopes and intercepts (these are the weighted averages of from 1 to 4 determinations) obtained by plotting the relaxation data according to Eq. 3, as shown in Fig. 5 . Since the value of (TlbO,ufd + TbOUfld) for nicotine is known, these slopes can be used to provide values for KD/KI (i.e., Knicotine/Kcompeting ligand). These values are then combined to give the results summarized in Table  III .
The dissociation constants measured here are for the high affinity, or desensitized state, since the receptors were at all times saturated with a large excess of ligand. Membrane fragments ach 0.003 [40] as 20% of the receptor is thought to be in the high affinity state. However, under the conditions used in this work (large stochiometric excess of acetylcholine or other agonist), essentially all of the receptor is in the high affinity state. Since this method requires a large excess of agonist, it would not work well for the low affinity state unless photolytic (34, 35) or flow methods were worked out to produce a limited amount of active molecule.
